← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Sao Paulo
Sao Paulo
$3,694,161
Total funding
7
Grants
Funding over time
peak $672K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,694,161 · 7
By mechanism
R01$3,346,482 · 4
R03$266,679 · 2
R21$81,000 · 1
Investigators at University Of Sao Paulo
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
The biological connection between educational attainment and attention-deficit/hyperactivity disorder in contrasting environments$539,536
R01 · FY2022 · MH
The biological connection between educational attainment and attention-deficit/hyperactivity disorder in contrasting environments$539,536
R01 · FY2023 · MH
The biological connection between educational attainment and attention-deficit/hyperactivity disorder in contrasting environments$539,082
R01 · FY2025 · MH
The biological connection between educational attainment and attention-deficit/hyperactivity disorder in contrasting environments$539,082
R01 · FY2024 · MH
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.$134,861
R01 · FY2021 · AI
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.$132,461
R01 · FY2022 · AI
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.$130,928
R01 · FY2024 · AI
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.$130,474
R01 · FY2023 · AI
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.$130,084
R01 · FY2025 · AI
Nerve Stimulation to Improve Hand Weakness in Stroke$81,000
R21 · FY2004 · TW
Population structure and transmission dynamics of Plasmodium vivax$79,200
R01 · FY2008 · AI
Population structure and transmission dynamics of Plasmodium vivax$78,606
R01 · FY2010 · AI
Population structure and transmission dynamics of Plasmodium vivax$78,600
R01 · FY2009 · AI
Population structure and transmission dynamics of Plasmodium vivax$78,032
R01 · FY2011 · AI
Biomarkers for detection of bladder cancer$54,000
R01 · FY2005 · TW
HIV-1 PROTEASE CD4+ T CELL EPITOPES AND DRUG-INDUCED MUTATIONS$54,000
R03 · FY2007 · AI
Biomarkers for detection of bladder cancer$54,000
R01 · FY2003 · TW
Biomarkers for detection of bladder cancer$54,000
R01 · FY2004 · TW
Mitochondrial Targets in Methylmalonic Acidemia$54,000
R03 · FY2005 · HD
Biomarkers for detection of bladder cancer$54,000
R01 · FY2002 · TW